MSH3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.452000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.066200E-02
Normal-vs-Stage2
5.514400E-01
Normal-vs-Stage3
1.397980E-01
Normal-vs-Stage4
2.199400E-01
Stage1-vs-Stage2
1.967950E-01
Stage1-vs-Stage3
4.015100E-03
Stage1-vs-Stage4
8.802200E-01
Stage2-vs-Stage3
1.006780E-01
Stage2-vs-Stage4
3.654400E-01
Stage3-vs-Stage4
4.478400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.314000E-01
Normal-vs-AfricanAmerican
4.649000E-01
Normal-vs-Asian
9.313000E-01
Caucasian-vs-AfricanAmerican
8.649000E-01
Caucasian-vs-Asian
5.382200E-01
AfricanAmerican-vs-Asian
5.990000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.005200E-01
Normal-vs-Female
6.187000E-01
Male-vs-Female
4.568400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.723700E-02
Normal-vs-Age(41-60Yrs)
4.197200E-01
Normal-vs-Age(61-80Yrs)
6.699600E-01
Normal-vs-Age(81-100Yrs)
4.398000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.230800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.522600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.250200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.026430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.985800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.614200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.324600E-01
Normal-vs-Daily Drinker
8.016800E-01
Normal-vs-Weekly Drinker
8.489600E-01
Normal-vs-Occasional Drinker
3.320200E-01
Normal-vs-Social Drinker
4.044800E-01
Non Drinker-vs-Daily Drinker
8.207600E-01
Non Drinker-vs-Weekly Drinker
3.346600E-01
Non Drinker-vs-Occasional Drinker
2.197200E-01
Non Drinker-vs-Social Drinker
4.124600E-01
Daily Drinker-vs-Weekly Drinker
4.417800E-01
Daily Drinker-vs-Occasional Drinker
1.607370E-01
Daily Drinker-vs-Social Drinker
3.097600E-01
Weekly Drinker-vs-Occasional Drinker
5.601900E-02
Weekly Drinker-vs-Social Drinker
1.103200E-01
Occasional Drinker-vs-Social Drinker
7.285600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.524100E-02
Normal-vs-Grade 2
1.216150E-02
Normal-vs-Grade 3
2.761100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.443600E-01
Grade 1-vs-Grade 3
2.429400E-01
Grade 1-vs-Grade 4
3.524100E-02
Grade 2-vs-Grade 3
2.545400E-01
Grade 2-vs-Grade 4
1.216150E-02
Grade 3-vs-Grade 4
2.761100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.709400E-01
Normal-vs-NonDiabetic
6.226000E-01
Diabetic-vs-NonDiabetic
3.108600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.434800E-01
Normal-vs-NoPancreatitis
6.203600E-01
Pancreatitis-vs-NoPancreatitis
9.368600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.769000E-01
Normal-vs-N1
5.131000E-01
N0-vs-N1
7.858400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.383600E-01
Normal-vs-TP53-NonMutant
2.660000E-01
TP53-Mutant-vs-TP53-NonMutant
4.757200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
